| Product Code: ETC9961281 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Breast Cancer Liquid Biopsy Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Breast Cancer Liquid Biopsy Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Breast Cancer Liquid Biopsy Market - Industry Life Cycle |
3.4 United States (US) Breast Cancer Liquid Biopsy Market - Porter's Five Forces |
3.5 United States (US) Breast Cancer Liquid Biopsy Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United States (US) Breast Cancer Liquid Biopsy Market Revenues & Volume Share, By Circulating Biomarkers, 2021 & 2031F |
3.7 United States (US) Breast Cancer Liquid Biopsy Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 United States (US) Breast Cancer Liquid Biopsy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of breast cancer in the United States |
4.2.2 Growing awareness and adoption of liquid biopsy as a non-invasive diagnostic tool |
4.2.3 Technological advancements in liquid biopsy techniques for breast cancer detection |
4.3 Market Restraints |
4.3.1 High cost associated with liquid biopsy tests |
4.3.2 Regulatory challenges and uncertainties surrounding liquid biopsy technologies |
4.3.3 Limited reimbursement policies for liquid biopsy tests |
5 United States (US) Breast Cancer Liquid Biopsy Market Trends |
6 United States (US) Breast Cancer Liquid Biopsy Market, By Types |
6.1 United States (US) Breast Cancer Liquid Biopsy Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Breast Cancer Liquid Biopsy Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 United States (US) Breast Cancer Liquid Biopsy Market Revenues & Volume, By Consumables, 2021- 2031F |
6.1.4 United States (US) Breast Cancer Liquid Biopsy Market Revenues & Volume, By Kits, 2021- 2031F |
6.2 United States (US) Breast Cancer Liquid Biopsy Market, By Circulating Biomarkers |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Breast Cancer Liquid Biopsy Market Revenues & Volume, By Extracellular Vesicles (EVs), 2021- 2031F |
6.2.3 United States (US) Breast Cancer Liquid Biopsy Market Revenues & Volume, By Cell-free DNA (cfDNA), 2021- 2031F |
6.2.4 United States (US) Breast Cancer Liquid Biopsy Market Revenues & Volume, By ctRNA, 2021- 2031F |
6.2.5 United States (US) Breast Cancer Liquid Biopsy Market Revenues & Volume, By Circulating Tumor Cells (CTCs), 2021- 2031F |
6.2.6 United States (US) Breast Cancer Liquid Biopsy Market Revenues & Volume, By cfRNA, 2021- 2031F |
6.2.7 United States (US) Breast Cancer Liquid Biopsy Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) Breast Cancer Liquid Biopsy Market, By End Users |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Breast Cancer Liquid Biopsy Market Revenues & Volume, By Laboratories, 2021- 2031F |
6.3.3 United States (US) Breast Cancer Liquid Biopsy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.4 United States (US) Breast Cancer Liquid Biopsy Market Revenues & Volume, By Physician Laboratories, 2021- 2031F |
6.3.5 United States (US) Breast Cancer Liquid Biopsy Market Revenues & Volume, By Reference Laboratories, 2021- 2031F |
6.3.6 United States (US) Breast Cancer Liquid Biopsy Market Revenues & Volume, By Public Health Laboratories, 2021- 2031F |
6.3.7 United States (US) Breast Cancer Liquid Biopsy Market Revenues & Volume, By Research Institutes, 2021- 2031F |
6.3.8 United States (US) Breast Cancer Liquid Biopsy Market Revenues & Volume, By Pathology Laboratories, 2021- 2031F |
6.3.9 United States (US) Breast Cancer Liquid Biopsy Market Revenues & Volume, By Pathology Laboratories, 2021- 2031F |
7 United States (US) Breast Cancer Liquid Biopsy Market Import-Export Trade Statistics |
7.1 United States (US) Breast Cancer Liquid Biopsy Market Export to Major Countries |
7.2 United States (US) Breast Cancer Liquid Biopsy Market Imports from Major Countries |
8 United States (US) Breast Cancer Liquid Biopsy Market Key Performance Indicators |
8.1 Average turnaround time for liquid biopsy test results |
8.2 Rate of adoption of liquid biopsy tests by healthcare providers |
8.3 Number of research studies and publications supporting the efficacy of liquid biopsy for breast cancer detection |
9 United States (US) Breast Cancer Liquid Biopsy Market - Opportunity Assessment |
9.1 United States (US) Breast Cancer Liquid Biopsy Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United States (US) Breast Cancer Liquid Biopsy Market Opportunity Assessment, By Circulating Biomarkers, 2021 & 2031F |
9.3 United States (US) Breast Cancer Liquid Biopsy Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 United States (US) Breast Cancer Liquid Biopsy Market - Competitive Landscape |
10.1 United States (US) Breast Cancer Liquid Biopsy Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Breast Cancer Liquid Biopsy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here